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Introduction
Klippel–Trenaunay syndrome (KTS) is a rare congeni-
tal mesodermal abnormality characterized by varicose 
veins, cutaneous capillary malformation, as well as bone 
and soft tissue hypertrophy.1 Usually these symptoms are 
limited to one extremity; however, multiple extremities, 
unilateral and even whole body involvement have been 
described.2-6 While lower extremity is the most common-
ly affected site, the arms, trunk, and rarely the head and 
neck may be involved, as well.7,8
Early diagnosis is important to avoid complications, such 
as pulmonary embolism, thrombophlebitis, haemor-
rhage, stasis dermatitis, and cutaneous ulcerations.9
There are absolute and relative indications for treatment 
of vascular malformations in KTS. The absolute indica-
tions include infections, acute thromboembolism, hae-
morrhage, or refractory ulcers. Relative indications for 
treatment are pain, functional impairment, swelling due 
to chronic venous insufficiency, limb asymmetry or cos-
metic reasons. The psychological problems of patient and 
his/her family, caused by a visible deformity of the KTS 
should not be underestimated and are important indica-
tions for treatment.10
Herein, we report a case of unilateral KTS with early di-
agnosis and successful treatment with pulsed-dye laser 
(PDL). 
Case Presentation
A 2-week-old female infant presented to our clinic be-
cause of vascular nevus and progressive enlargement of 
her right extremities and trunk since birth. The patient 
was the result of a normal vaginal delivery at full term, 
with a birth weight of 3.1 kg. Her parents were non-con-
sanguineous. Her mother denied consumption of any 
medication during pregnancy. The family history was un-
remarkable.
Physical examination showed a large, irregular, pink-to-
purple patch (compatible with port-wine stain [PWS]) 
over the right hemiside of her body (trunk, lower and 
upper extremity) (Figure 1). There was some soft-tissue 
hypertrophy both in right trunk and right limbs; however, 
mild difference in limb length was detected only in lower 
extremity. Color duplex ultrasonography showed no sub-
cutaneous vascular malformation.
The patient was treated with 595-nm PDL at 10-11 J/
cm2, 1.5-3 ms pulse duration, and 7-mm spot size, for 3 
sessions with 3-week intervals. She also received elastic 
compression dressing for one year. Her PWS disappeared 
completely after third PDL session and the soft tissue hy-
pertrophy stopped. The patient experienced neither re-
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Discussion
In this article, we reported a patient with unilateral KTS 
who presented to our clinic at a very early stage of her dis-
ease (when she was only 2 weeks old). The PWS cleared 
completely after receiving only 3 sessions of PDL with 
no recurrence after 7 years of follow up. Our experience 
shows that early intervention at younger age is associated 
with increased response to PDL.
Management of vascular manifestations of KTS is usually 
conservative with compression therapy. Although, wear-
ing of compression garments/bandages is efficacious for 
patients with limb hypertrophy, venous stasis, and phle-
bitis, their application may cause problems for rapidly 
growing infants and small children.11 Furthermore, many 
parents have difficulty in encouraging their child to wear 
the garment. 
PDL is currently the treatment of choice for these capil-
lary malformations. However, the extent to which these 
lesions may improve varies widely and complete resolu-
tion is infrequent.12
Woo et al reported only 2% of patients with complete 
disappearance of lesion after a mean of 17 treatment 
sessions.13
While PDL is very effective in producing initial lightening 
of PWS lesions, there is a subsequent revascularization 
after laser therapy that results in frequent treatment fail-
ure. This failure has been hypothesized to occur through 
post-laser angiogenesis via the induction of the hypoxia 
inducible factor-1a (HIF-1a)14 and VEGF pathways.15,16 
Resolution of PWS, as defined by persistent blanching of 
the lesion, is reported in less than 10%–20% of cases.12,17-20 
Early intervention is indicated to prevent the development 
of hypertrophy and nodularity, which has been shown to 
increase treatment resistance.12,21
Thickened PWS lesions at older age have been associated 
with increased therapeutic failure.
Sclerotherapy, selective endovenous thermal ablation, 
surgical stripping, phlebectomy, and occasionally, deep 
vein reconstructions are other more invasive therapeutic 
Figure 1. Large port-wine stain and Soft Tissue Hypertrophy 
(Compatible With Klippel–Trenaunay Syndrome ) Over the  Right 
Hemiside of the Body of a 2-Week-Old Infant (Trunk, Lower and 
Upper Extremity).
Figure 2. Complete Regression of the Port-wine stain and Cessation 
of Soft Tissue Hypertrophy in Trunk (A), Upper Limb (B), and Lower 
Limb (C) After 3 Sessions of Treatment With Pulsed Dye Laser. No 
recurrence was observed after 7 years.
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options for KTS which are recommended to be saved for 
refractory lesions.
To our knowledge, this is the first case of KTS which is 
treated with PDL successfully with no recurrence after 
7 years of follow up. The use of PDL in “early stage” of 
disease is the substantial key point, as it results in: (1) de-
creased risk of treatment failure, (2) decreased risk of re-
currence of the lesion, (3) less laser sessions to achieve the 
complete resolution of the lesion.
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